SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-095143
Filing Date
2023-08-25
Accepted
2023-08-25 09:00:14
Documents
4
Period of Report
2023-10-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2323781d2_def14a.htm DEF 14A 163403
2 GRAPHIC tm2323781d1_pre14aimg01.jpg GRAPHIC 5709
3 GRAPHIC tm2323781d1_pre14aimg02.jpg GRAPHIC 228839
4 GRAPHIC tm2323781d1_pre14aimg03.jpg GRAPHIC 114481
  Complete submission text file 0001104659-23-095143.txt   645694
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35366 | Film No.: 231203980
SIC: 2834 Pharmaceutical Preparations